DK0958351T3 - Chimere målmolekyler med regulerbar aktivitet - Google Patents

Chimere målmolekyler med regulerbar aktivitet

Info

Publication number
DK0958351T3
DK0958351T3 DK97952131.7T DK97952131T DK0958351T3 DK 0958351 T3 DK0958351 T3 DK 0958351T3 DK 97952131 T DK97952131 T DK 97952131T DK 0958351 T3 DK0958351 T3 DK 0958351T3
Authority
DK
Denmark
Prior art keywords
molecule
binding molecule
chimeric
activity
binding
Prior art date
Application number
DK97952131.7T
Other languages
English (en)
Inventor
Daniel Legendre
Patrice Soumillion
Jacques Fastrez
Original Assignee
Univ Catholique Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25047774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0958351(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Catholique Louvain filed Critical Univ Catholique Louvain
Application granted granted Critical
Publication of DK0958351T3 publication Critical patent/DK0958351T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
    • C12Y305/02006—Beta-lactamase (3.5.2.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK97952131.7T 1996-11-27 1997-11-26 Chimere målmolekyler med regulerbar aktivitet DK0958351T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/757,425 US6500660B1 (en) 1996-11-27 1996-11-27 Chimeric target molecules having a regulatable activity
PCT/IB1997/001643 WO1998023731A2 (en) 1996-11-27 1997-11-26 Chimeric target molecules having a regulatable activity

Publications (1)

Publication Number Publication Date
DK0958351T3 true DK0958351T3 (da) 2010-03-15

Family

ID=25047774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97952131.7T DK0958351T3 (da) 1996-11-27 1997-11-26 Chimere målmolekyler med regulerbar aktivitet

Country Status (10)

Country Link
US (1) US6500660B1 (da)
EP (1) EP0958351B1 (da)
JP (1) JP4416185B2 (da)
AT (1) ATE449166T1 (da)
AU (1) AU5571998A (da)
DE (1) DE69739664D1 (da)
DK (1) DK0958351T3 (da)
ES (1) ES2336634T3 (da)
PT (1) PT958351E (da)
WO (1) WO1998023731A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004530411A (ja) * 2000-11-08 2004-10-07 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション 抗菌化合物の同定方法
AU2002322280A1 (en) 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
KR100428998B1 (ko) * 2001-09-10 2004-04-28 한국과학기술원 모체 단백질과는 크기와 서열이 다른 단백질의 변이집단을생산하는 방법
GB0209878D0 (en) * 2002-04-30 2002-06-05 Glaxosmithkline Biolog Sa Vaccine
WO2009154461A1 (en) * 2008-06-19 2009-12-23 Prothix Bv Use of anti-factors xi antibodies for prevention of thrombus formation
DE102022000897A1 (de) 2022-03-15 2023-09-21 Ruhr-Universität Bochum, Körperschaft des öffentlichen Rechts Implantierbarer Biosensor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002757A1 (en) * 1986-10-17 1988-04-21 Saramane Pty. Ltd.; Hybrid proteins or polypeptides
WO1990004788A1 (en) * 1988-10-28 1990-05-03 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants
CA2094495C (en) * 1990-10-22 2007-04-03 David Botstein Methods for modifying and detecting the effects on the interaction of modified polypeptides and target substrates
WO1993022450A1 (en) * 1992-05-07 1993-11-11 The Regents Of The University Of California Novel diphtheria toxin-based molecules
US5674681A (en) * 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis

Also Published As

Publication number Publication date
WO1998023731A3 (en) 1998-11-12
ES2336634T3 (es) 2010-04-14
AU5571998A (en) 1998-06-22
JP4416185B2 (ja) 2010-02-17
EP0958351B1 (en) 2009-11-18
WO1998023731A2 (en) 1998-06-04
PT958351E (pt) 2010-02-17
EP0958351A2 (en) 1999-11-24
JP2001515346A (ja) 2001-09-18
DE69739664D1 (de) 2009-12-31
US6500660B1 (en) 2002-12-31
ATE449166T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
DE69638269D1 (de) Hochaffine humane antikörper gegen tumorantigene
ATE165397T1 (de) Screeningtest für den nachweis von dna-bindenden molekülen
DE69835143D1 (de) Selektion von proteinen mittels rns-protein fusionen
WO1998035693A3 (en) Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
ATE267394T1 (de) Nachweis der krankheitsbedingten konformation eines proteins
WO1998010795A3 (en) Tumor homing molecules, conjugates derived therefrom, and methods of using same
ATE555202T1 (de) Verfahren zur lieferung von rna-interferenz und verwendungen damit
ATE348175T1 (de) Method eder intrazellularen bindung von zielgerichteten molekülen
ATE246361T1 (de) Verfahren zur bestimmung von ige
DK0590071T3 (da) Hovedsagelig rene receptor-lignende TGF-BETA-1 bindende molekyler samt anvendelse deraf
DE69531309D1 (de) Entwurf diskontinuierlicher sonden unter verwendung von hybritopemapping
AU7532501A (en) Method for increasing luminescence assay sensitivity
ATE383172T1 (de) Oligonukleotide welche spezifisch retrovirale nukleokapsid-proteine binden
ATE236401T1 (de) Surrogate für bindemoleküle und verbesserte referenzpanele
ATE449166T1 (de) Chimere zielmoleküle mit regulierbarer aktivität
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
DE69919503D1 (de) Verfahren zur bestimmung eines analyten und kit dafür
BRPI0416270A (pt) método para detectar um analito em uma amostra, e, método e kit para detectar um anticorpo especìfico de uma amostra
WO2004069860A3 (en) Isg15-conjugated proteins
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики
EA199900387A1 (ru) Полипептиды, содержащие домены протеина gax, участвующие в подавлении транскрипции и/или взаимодействующие с другими протеинами, соответствующие нуклеиновые кислоты и их применение
ATE269905T1 (de) Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
WO2001061001A3 (de) Neues zentralnervöses protein, das k+-ströme moduliert
JP2002539457A5 (da)